West Pharmaceutical Services, Inc. (WST) is a publicly traded Healthcare sector company. As of October 26, 2026, WST trades at $398.38 with a market cap of $27.60B and a P/E ratio of 46.25. WST moved +0.66% today. Year to date, WST is +42.81%; over the trailing twelve months it is +32.70%. Its 52-week range spans $187.43 to $397.16. Analyst consensus is strong buy with an average price target of $418.67. Rallies surfaces WST's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
West Pharma shares rise 3.4% after new $950 million credit agreement: West Pharmaceutical Services shares rose 3.4% in extended trading after it repaid $130 million and terminated its 2019 credit agreement without early repayment penalties. Its new five-year financing agreement includes a $750 million revolving facility and a $200 million term loan.
| Metric | Value |
|---|---|
| Price | $398.38 |
| Market Cap | $27.60B |
| P/E Ratio | 46.25 |
| EPS | $7.87 |
| Dividend Yield | 0.26% |
| 52-Week High | $397.16 |
| 52-Week Low | $187.43 |
| Volume | 529.06K |
| Avg Volume | 0 |
| Revenue (TTM) | $3.33B |
| Net Income | $564.90M |
| Gross Margin | 36.79% |
6 analysts cover WST: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $418.67.